Crossref
Adoptive immunotherapy of cancer using effector lymphocytes redirected with antibody specificity
Update on Cancer Therapeutics · 2006
DOI: 10.1016/j.uct.2006.04.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Update on Cancer Therapeutics, 2006. Verfasst von Dinorah Friedmann-Morvinski und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 73 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Friedmann-Morvinski, D., & Eshhar, Z. (2006). Adoptive immunotherapy of cancer using effector lymphocytes redirected with antibody specificity. Update on Cancer Therapeutics. https://doi.org/10.1016/j.uct.2006.04.005
Vancouver
Friedmann-Morvinski D, Eshhar Z. Adoptive immunotherapy of cancer using effector lymphocytes redirected with antibody specificity. Update on Cancer Therapeutics. 2006. doi:10.1016/j.uct.2006.04.005
BibTeX
@article{FriedmannMorvinski2006,
author = {Friedmann-Morvinski, Dinorah and Eshhar, Zelig},
title = {Adoptive immunotherapy of cancer using effector lymphocytes redirected with antibody specificity},
journal = {Update on Cancer Therapeutics},
year = {2006},
doi = {10.1016/j.uct.2006.04.005}
}
EUVIMED